Mimicking biological functionality with polymers for biomedical applications

Purpose: Biomaterials must increasingly do more than simply avoid rejection; they must actively mimic biological structures and functions to direct cell behavior, modulate immunity, and repair tissues. This review addresses how biologically inspired polymers can be designed for local tissue engineering, systemic therapeutic functions, and interfacial applications such as adhesives and lubricious coatings.

Hypothesis: This is a review article and does not test a single formal hypothesis. Its central premise is that mimicking natural physical, chemical, and biological properties with synthetic and hybrid polymeric materials — hydrogels, nanoparticles, artificial cells, and bioinspired coatings — can produce biocompatible systems capable of directing complex biological functions for therapeutic benefit.

Aims: Review strategies to create synthetic environments that mimic tissues, including hydrogels, dynamic hydrogels, biological cues, and external manipulation. - Describe polymeric systems for systemic function, including synthetic pathogens, artificial antigen-presenting cells, platelet mimics, and immunomodulatory particles. - Discuss biomimetic materials for interfacial function, including tissue adhesives and antifouling/lubricating coatings inspired by mussels, geckos, sandcastle worms, beetles, cactus, pitcher plants, and lubricin. - Highlight future perspectives, especially immune system manipulation and the need for mechanistic understanding of biomaterial–immune interactions.

Delivery system: Local tissue systems: Hydrogels as ECM mimics; synthetic and natural polymer scaffolds; dynamic hydrogels with enzyme-sensitive crosslinks, photo-responsive linkers, and tunable mechanical properties; decellularized ECM scaffolds. - Systemic systems: Polymeric nanoparticles and microparticles; synthetic viruses/pathogens; artificial antigen-presenting cells (aAPCs); platelet-like nanocapsules; erythrocyte-, cancer cell-, platelet-, leukocyte-, macrophage-, and stem-cell membrane-coated particles. - Interfacial systems: Mussel-inspired wet adhesives; gecko-inspired tissue adhesives; sandcastle-worm-inspired nanoglue; slippery liquid-infused coatings; bottlebrush polymer lubricants. - Payloads / bioactive cues: Growth factors (VEGF), cytokines, antigens, DNA, peptides (RGD, CD47 mimetic, ECM-binding motifs), proteins (vitronectin), cells, and immune signals. - Targeting / functional ligands: Cell-adhesion peptides, ECM-binding domains, TLR agonists, phosphatidylserine, MHC/co-stimulatory molecules, and membrane-derived surface molecules.

Approach: Review of in vitro, in vivo, preclinical, clinical, and commercial literature. Model systems include stem cells, immune cells, cancer cells, islet/beta cells, and animal models such as mice, rats, pigs, and non-human primates. Tissue sources include synthetic, natural, and decellularized ECM. No new primary experiments are reported.

Key methods: Hydrogel synthesis, crosslinking, mechanical characterization (elasticity, viscoelasticity, stiffness), swelling, and degradation. - Cell culture, stem-cell differentiation, migration, proliferation, and phenotype assays. - In vivo implantation, wound healing, bone formation, vascularization, immune response, and foreign-body reaction. - Nanoparticle/microparticle characterization, shape control, surface modification, and biodistribution. - Immune cell activation, T-cell expansion, cytokine production, and antigen presentation. - Tissue adhesion, wet adhesion, lubrication, antifouling, and thrombosis assays. - High-throughput screening of ECM materials and combinatorial hydrogel libraries.

Key results: Worm-like polymeric DNA nanoparticles delivered genes to rat liver with expression two and three orders of magnitude higher than rod-like nanoparticles and nanospheres, respectively. - Ellipsoidal aAPCs with high aspect ratio showed superior efficacy for CD8+ T-cell activation compared with spherical aAPCs of the same volume and surface protein content. - Encapsulated insulin-producing human stem-cell-derived beta cells survived for approximately 6 months in vivo and maintained glucose control in mice. - Less than 1% of an administered cancer treatment was found to reach solid tumors in a meta-analysis of traditional nanomedicine approaches. - Enzyme-sensitive peptide crosslinkers in hydrogels increased bone formation in cranial defects in mice. - Photo-cleavable RGD in PEG hydrogels initially enhanced cartilage generation from MSCs but later inhibited it; light-based cleavage after one week restored cartilage formation. - Implant size of 1.5 mm and greater was most effective at reducing foreign-body reactions across multiple materials.

Interpretation: Biomimetic polymers can actively direct cell behavior, modulate the immune system, promote tissue regeneration, and provide systemic therapeutic functions. The immune system is a particularly important target: materials can be designed to stimulate or suppress immune responses, avoid fibrosis, and enhance cancer immunotherapy. However, the field still needs an in-depth, mechanistic understanding of how biomaterials interact with the immune system locally and systemically. Biologists and engineers must work together to translate these materials into clinically effective therapies.

Limitations: This is a review, not a primary study; no new experimental data or meta-analysis. - Many biomimetic technologies remain preclinical; few dynamic scaffolds have reached clinical testing. - Hydrogels with numerous biological and chemical modifications can be difficult to manufacture and face complex regulatory pathways. - Prediction of in vivo and clinical responses is challenging, especially in diseased or abnormal environments. - The efficiency of systemic nanomedicine delivery to solid tumors remains very low (<1% in the cited meta-analysis). - Long-term safety, large-animal validation, and immune interactions require further mechanistic study.